Vericel Corp. (VCEL)

[hurley cruppers]

Just made a major discovery, you will be impressed. IN BOLD BELOW

PLENARY SESSION: IMPLICATIONS OF COMMERCIALIZATION: WHAT DOES APPROVAL MEAN? {Ballroom 1}
This is CAR-T cell therapy’s breakthrough year. The first product, Novartis’ Kymriah, is now approved to treat acute lymphoblastic lymphoma, and therapies for other cancers are hot on its heels. This panel will explore the scientific, clinical, policy and business issues surrounding CAR-T approvals, and set the stage for moving these therapies into mainstream medicine.

Chair:
Amy DuRoss, CEO, Vineti

Speakers:
Bob Azelby, EVP, Chief Commercial Officer, Juno Therapeutics
Nick Colangelo, President and CEO, Vericel Corporation
Pascal Touchon, D.V.M., SVP and Global Head, Cell and Gene, Novartis Oncology
Jeffrey Walsh, Chief Financial and Strategy Officer, bluebird bio

https://vineti.com/about/
http://vcel.com/about-vericel/#BoardOfDirectors

Click the links and see if you see someone in common

VCEL